株式会社極東書店トップ商品一覧Cancer Systems Biology: Translational Mathematical Oncology.

商品詳細

Cancer Systems Biology: Translational Mathematical Oncology.

Cancer Systems Biology: Translational Mathematical Oncology.

・ISBN 978-0-19-286763-6 hard GB£ 155.00

¥49,104.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
電子版あり 大学・学術機関向け電子ブック(eBook)ISBN 9780191959714
著者・編者Salgia, Ravi / Jolly, Mohit Kumar / Kulkarni, Prakash / Rangarajan, Govindan,
出版社 (Oxford University Press, UK)
出版年月2025
ページ数480 pp.
言語ENG
ニュース番号<A04-60141>

解説

Over the centuries, civilization has seen considerable advances in healthcare. Cancer is among the most challenging healthcare issues that we face today, but a number of discoveries have led to better care. Despite all the progress and the promise regarding early detection and precision medicine, we are still faced with the nettlesome problem - cancer is a moving target. Even within an individual tumour, deep sequencing analyses now indicate multiple, phenotypically distinct subpopulations, whose representation seems to vary dramatically from one stage to the next as the tumour progresses. Cancer Systems Biology provides state-of-the-art reviews and thought-provoking ideas in a concise and succinct manner. This insightful textbook is a crosspollination of concepts from multiple disciplines and experimental approaches to study cancer. The chapters provide new ideas and thoughts outlining how a quantitative picture of cancer can provide a deeper understanding of the disease, and how a systems level perspective may hold the key to fully comprehend how cancer arises and progresses. Written by experts in multiple disciplines, including systems biologists, science researchers, physicists, mathematicians, and clinicians, Cancer Systems Biology provides a comprehensive, up-to-date, treatise devoted to understanding cancer from a systems perspective. Providing new conceptual insights that can aid precision medicine, it will be essential reading for academic researchers in the field, clinicians, graduate students, and scientists with an interest in cancer biology.